Safety Evaluation of Biatain Ibu in Painful Chronic Venous Leg Ulcers

An Open Label Extension Study (to Study DK143WS) Evaluating the Safety and Long-term Safety Follow-up of Biatain Ibu in Painful Chronic Venous Leg Ulcers

The objective of this open label extension study (extension to study DK143WS) is to evaluate the safety of Biatain Ibu during 6 -12 weeks of exposure and during a 40 - 46 weeks safety follow-up period.

Inclusion Criteria:

• The patient has participated in study DK143WS
• The patient is able to understand the treatment and is willing to comply with the treat-ment regimen.
• The patient is willing and able to give written informed consent

Exclusion Criteria:

• Pregnant or lactating women
• Concomitant participation in other studies